Effects of diabetes on reactivity of sciatic vasa nervorum in rats

Journal of Diabetes and its Complications

Volumn 11, Issue 1, 1997, Pages 47-55

  Maxfield, Emily K ^a   Cameron, Norman E ^a   Cotter, Mary A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GLYCERYL TRINITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PERINEURIUM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TIME; VASCULAR ENDOTHELIUM;

EID: 0031040690     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00112-2     Document Type: Article

References (65)

1. 1. Low PA, Lagerlund TD, McManis PG: Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int Rev Neurobiol 31:355-438, 1989.
2. 2. Cameron NE, Cotter MA: The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 10:189-224, 1994.
3. 3. Tesfaye S, Malik R, Ward JD: Vascular factors in diabetic neuropathy. Diabetologia 37:847-854, 1994.
4. 4. Cameron NE, Cotter MA, Dines KC, Maxfield EK, Carey F, Mirrlees DJ: Aldose reductase inhibition, nerve perfusion, oxygenation and function in striptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism. Diabetologia 37:651-663, 1994.
5. 5. Cameron NE, Cotter MA, Dines KC, Hohman TC: Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats. J Diabet Complications 10(in press), 1996.
6. 6. Calcutt NA, Mizisin AP, Kalichman MW: Aldose reductase inhibition, Doppler Flux and conduction in diabetic rat nerve. Eur J Pharmacol 251:27-33, 1994.
7. 7. Hotta N, Kaskuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima E, Inukai S, Sakamoto N: Effect of a potent new aldose reductase inhibitor (5-(3-thienyl)tetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats. Diabetes Res Clin Pract 27:107-117, 1995.
8. 8. Bravenboer B, Kapelle AC, Hamers FPT, Van Buren T, Irkelens DW, Gispen WH: Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 35:813-817, 1992.
9. 9. Cameron NE, Cotter MA, Maxfield EK: Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36:299-394, 1993.
10. 10. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK: Anti-oxidant and pro-oxidant effects on nerve conduction velocity and endoneurial blood flow and oxygen tensions in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37:449-459, 1994.
11. 11. Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC: Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38:1285-1294, 1995.
12. 12. Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR: Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats. Comparison with essential fatty acids. Diabetologia 38:129-134, 1995.
13. 13. Julu POO: Essential fatty acids prevent slowed nerve conduction in streptozotocin diabetes. J Diabet Complications 2:185-188, 1988.
14. 14. Cameron NE, Cotter MA: Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin-diabetic rats. Acta Diabetol 31:220-225, 1994.
15. 15. Dines KC, Cameron NE, Cotter MA: Comparison of the effects of evening primrose oil and triglycerides containing γ-linolenic acid on nerve conduction and blood flow in diabetic rats. J Pharmacol Exp Ther 273:49-55, 1995.
16. +-ATPase activity, and vascular supply in STZ-D rats. Diabetes 40:1652-1658, 1991.
17. 17. Cameron NE, Cotter MA, Low PA: Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261:E1-E8, 1991.
18. 18. Cotter MA, Cameron NE: Neuroprotective effects of carvedilol in diabetic rats: prevention of defective peripheral nerve perfusion and conduction velocity. Naunyn Schmeidebergs Arch Pharmacol 351:630-635, 1995.
19. 19. Maxfield EK, Cameron NE, Cotter MA, Dines KC: Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats. Diabetologia 36:1230-1237, 1993.
20. 20. Kapelle AC, Biessels GJ, Van Buren T, Erkelens DW, De Wildt DJ, Gispen WH: Effects of nimodipine on sciatic nerve blood flow and vasa nervorum vascular responsiveness in the diabetic rat. Eur J Pharmacol 250:43-49,1993.
21. 2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. Br J Pharmacol 111:887-893, 1994.
22. 22. Reja A, Tesfaye S, Harris ND, Ward JD: Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabetic Med 12:307-309, 1995.
23. 23. Oyama Y, Kawasaki H, Hattori Y, Kanno M: Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 131:75-78, 1986.
24. 24. Durante W, Sen AK, Sunahara FA: Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol 94:463-468, 1988.
25. 25. Takiguchi Y, Satoh N, Hashimoto H, Nakashima M: Reversal effect of thyroxine on altered vascular reactivity in diabetic rats. J Cardiovasc Pharmacol 13:520-524, 1989.
26. 26. Cameron NE, Cotter MA: Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: Role of the polyol pathway. Diabetologia 35:1011-1019, 1992.
27. 27. Langenstroer P, Pieper GM: Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 263:257-H265, 1992.
28. 28. Otter DJ, Chess-Williams R: The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats. Br J Pharmacol 113:576-580, 1994.
29. 29. Harris KH, MacLeod KM: Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol 153:55-64, 1988.
30. 30. Taylor PD, McCarthy AL, Thomas CR, Poston L: Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. Br J Pharmacol 107:393-339, 1992.
31. 31. Kihara M, Lowe PA: Regulation of rat nerve blood flow: Role of epineurial α-receptors. J Physiol 422:145-152, 1990.
32. 32. Cameron NE, Cotter MA, Dines KC, Maxfield EK: 1993, Pharmacological manipulation of vascular endothelium in non-diabetic and striptozotocin-diabetic rats: Effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36:516-522, 1993.
33. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 94:853-859, 1994.
34. 34. Kihara M. Low PA: Vasoreactivity to prostaglandins of rat peripheral nerve. J Physiol 484:463-467, 1995.
35. 35. Zochodne DW, Ho LT, Gross PM: Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve. Am J Physiol 263:H1806-1810, 1992.
36. 36. Nukuda H, Powell HC, Myers RR: Perineurial window: Demyelination in nonherniated endoneurium with reduced nerve blood flow. J Neuropathol Exp Neurol 51:523-530, 1992.
37. 37. McManis PG, Low PA: Factors affecting the relative viability of centrifascicular and subperineurial axons in acute peripheral nerve ischemia. Exp Neurol 99:84-95, 1988.
38. 38. Zochodne DW, Low PA: Adrenergic control of nerve blood flow. Exp Neurol 109:300-307, 1990.
39. 39. Simpson LO: Altered blood rheology in the pathogenesis of diabetic and other neuropathies. Muscle Nerve 11:725-744, 1988.
40. 40. Sutera, SP, Chang K, Marvel J, Williamson JR: Concurrent increases in regional hematocrit and blood flow in diabetic rats: Prevention by sorbinil. Am J Physiol 263:H945-H950, 1992.
41. 41. Agrawal DK, McNeill JH: Vascular responses to agonists in rat mesenteric artery from diabetic rats. Can J Physiol Pharmacol 65:1484-1490, 1987.
42. 42. MacLeod KM: The effect of insulin treatment on changes in vascular reactivity in chronic experimental diabetes. Diabetes 34:1160-1167, 1985.
43. 43. White RE, Carrier GO: Enhanced vascular α-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol 255:H1036-H1024, 1988.
44. 44. Friedman JJ: Vascular sensitivity and reactivity to norepinephrine in diabetes mellitus. Am J Physiol 256:H1134-H1138, 1989.
45. 45. Lucas PD: Effects of streptozotocin-induced diabetes and noradrenaline infusion on cardiac output and its regional distribution in pithed rats. Diabetologia 28:108-112, 1985.
46. 46. Ramanadham S, Lyness WH, Tenner TE Jr: Alterations in aortic and tail artery reactivity to agonists after streptozotocin treatment. Can J Physiol Pharmacol 62:418-423, 1984.
47. 47. Bhardwaj R, Moore PK: Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmacol 40:739-742, 1988.
48. 48. Hebden RA, Bennett T, Gardiner SM: Pressor sensitivities to vasopressin, angiotensin II or methoxamine in diabetic rats. Am J Physiol 253:R726-R734, 1987.
49. 49. Jackson CV, Carrier GO: Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat. J Cardiovasc Pharmacol 5:250-265, 1983.
50. 50. Cameron NE, Dines KC, Cotter MA: The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Diabetologia 37:1209-1215, 1994.
51. 51. Kihara M, Low PA: Impaired vasoreactivity to nitric oxide and endothelin vasoreactivity in experimental diabetic neuropathy. Neurology 44 (suppl 2):A274-A275, 1994.
52. 52. Rubanyi GM, Romero JC, Vanhoutte PM: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250:H1145-H1149, 1986.
53. 53. Pelligrino DA, Miletich DJ, Albrecht RF: Diminished muscarinin receptor-mediated cerebral blood flow response in streptozotocin-treated rats. Am J Physiol 262:E477-E454, 1992.
54. 54. Bell MA, Weddell AGM: A descriptive study of the blood vessels of the sciatic nerve in the rat, man and other mammals. Brain 107:871-898, 1994.
55. 55. Kihara M, Zollman PJ, Smithson IL, Lagerlund TD, Low PA: Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. Am J Physiol 266:E980-E985, 1994.
56. 56. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide, physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991.
57. 57. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87[suppl V]:V-67-V-76, 1993.
58. 58. Hill MA, Ege EA: Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats: Effect of aminoguanidine treatment. Diabetes 43:1450-1456, 1994.
59. 59. Mayhan WG: Impairment of endothelium-dependent dilation of cerebral arterioles during diabetes mellitus. Am J Physiol 256:H621-H625, 1989.
60. G-nitro-L-arginine. Am J Physiol 263:H1090-H1094, 1992.
61. 61. Ward KK, Low PA, Schmelzer JD, Zochodne DW: Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes. Brain 112:197-208, 1989.
62. 62. Cameron NE, Cotter MA: Effects of chronic treatment with a nitric oxide donor on nerve conduction abnormalities and endoneurial blood flow in streptozotocin-diabetic rats. Eur J Clin Invest 25:19-24, 1995.
63. 63. Baynes JW: Role of oxidative stress in the development of complications in diabetes. Diabetes 40:405-412, 1991.
64. 64. Wolff SP, Jiang ZY, Hunt JV: Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10:339-352, 1991.
65. 65. Cameron NE, Cotter MA: Neurovascular dysfunction in diabetic rats: Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J Clin Invest 96:1159-1163, 1995.